DO WE USE METHYLATION OF NFATC1 AND FOS GENES AS
A BIOMARKER FOR POSTMENOPAUSAL OSTEOPOROSIS?
Kalkan R, Tosun O
*Corresponding Author: Associate Professor Rasime Kalkan, Department of Medical Genetics, Faculty
of Medicine, Near East University, Near East Boulevard, Nicosia, Cyprus, 99138. Tel: +903-92-
223-6464. Fax: +903-92-223-6461. E-mail: rasime.kalkan@neu.edu.tr, kalkanr@yahoo.com
page: 35
|
|
REFERENCES
1. López-Rodríguez C, Aramburu J, Jin L, Rakeman
AS, Michino M, et al. Bridging the NFAT and NFkappaB
families: NFAT5 dimerization regulates
cytokine gene transcription in response to osmotic
stress. Immunity. 2001; 15(1): 47-58.
2. Hogan PG, Chen L, Nardone J, Rao A. Transcriptional
regulation by calcium, calcineurin, and NFAT. Genes
Dev. 2003; 17(18): 2205-232.
3. Wu H, Peisley A, Graef IA, Crabtree GR. NFAT signaling
and the invention of vertebrates. Trends Cell
Biol. 2007; 17(6): 251-260.
4. Pan MG, Xiong Y, Chen F. NFAT gene family in inflammation
and cancer. Curr Mol Med. 2013; 13(4):
543-554.
5. Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M,
Yoshida H, et al. Induction and activation of the transcription
factor NFATc1 (NFAT2) integrate RANKL
signaling in terminal differentiation of osteoclasts.
Dev Cell. 2002; 3(6): 889-901.
6. Matsumoto M, Kogawa M, Wada S, Takayanagi H,
Tsujimoto M, Katayama S, et al. Essential role of
p38 mitogen-activated protein kinase in cathepsin K
gene expression during osteoclastogenesis through
association of NFATc1 and PU.1. J Biol Chem. 2004;
279(44): 45969-45979.
7. Kim K, Kim JH, Lee J, Jin HM, Lee SH, Fisher DE,
et al. Nuclear factor of activated T cells c1 induces
osteoclast-associated receptor gene expression during
tumor necrosis factor-related activation-induced
cytokine-mediated osteoclastogenesis. J Biol Chem.
2005; 280(42): 35209-35216.
8. Chen S, Pan M. NFAT signaling and bone homeostasis.
J Hematol Thromb Dis. 2013; 1(1): 102-108.
9. Kim JH, Kim N. Regulation of NFATc1 in osteoclast
differentiation. J Bone Metab. 2014; 21(4): 233-241.
10. Huang H, Chang EJ, Ryu J, Lee ZH, Lee Y, Kim
HH. Induction of c-Fos and NFATc1 during RANKLstimulated
osteoclast differentiation is mediated by the p38 signaling pathway. Biochem Biophys Res
Commun. 2006; 351(1): 99-105.
11. Grigoriadis AE, Wang ZQ, Cecchini MG, Hofstetter
W, Felix R, Fleisch HA, et al. c-Fos: A key regulator
of osteoclast-macrophage lineage determination and
bone remodeling. Science. 1994; 266(5184): 443-448.
12. Marini F, Cianferotti L, Brandi ML. Epigenetic mechanisms
in bone biology and osteoporosis: Can they
drive therapeutic choices? Int J Mol Sci. 2016; 17(8):
1329.
13. Wang J, Zhang W, Yu C, Zhang X, Zhang H, Guan
Q, et al. Follicle stimulating hormone increases the
risk of postmenopausal osteoporosis by stimulating
osteoclast differentiation. PLoS One. 2015; 10(8):
e0134986.
14. Trošt Z, Trebše R, Preželj J, Komadina R, Logar DB,
Marc J. A microarray based identification of osteoporosis-
related genes in primary culture of human
osteoblasts. Bone. 2010; 46(1): 72-80.
15. Ichikawa T, Horie-Inoue K, Ikeda K, Blumberg B,
Inoue S. Vitamin K2 induces phosphorylation of protein
kinase A and expression of novel target genes
in osteoblastic cells. J Mol Endocrinol. 2007; 39(4):
239-247.
16. Liu YZ, Dvornyk V, Lu Y, Shen H, Lappe JM, Recker
RR, et al. A novel pathophysiological mechanism for
osteoporosis suggested by an in vivo gene expression
study of circulating monocytes. J Biol Chem. 2005;
280(32): 29011-29016.
17. Leclerc N, Luppen CA, Ho VV, Nagpal S, Hacia JG,
Smith E, et al. Gene expression profiling of glucocorticoid-
inhibited osteoblasts. J Mol Endocrinol.
2004; 33(1): 175-193.
18. Chen XD, Xiao P, Lei SF, Liu YZ, Guo YF, Deng
FY, et al. Gene expression profiling in monocytes
and SNP association suggest the importance of the
STAT1 gene for osteoporosis in both Chinese and
Caucasians. J Bone Miner Res. 2010; 25(2): 339-355.
19. Kalkan R, Altarda M, Tulay P, Tosun Ö. The interaction
between ESRRA and PTH gene methylation and
body mass index in post-menopausal cases. Cyprus
J Med Sci. 2019; 4(3): 247-250.
20. Raje MM, Mhaske ST, Ghosh P, Wani RM, Ashma
R. Differential gene expression pattern in osteoclast
precursor cells of Indian postmenopausal women with
and without osteoporosis: A microarray based study.
J Bone Res. 2017; 5(3): 185-192.
21. Raggatt LJ, Partridge NC. Cellular and molecular
mechanisms of bone remodeling. J Biol Chem. 2010;
285(33): 25103-25108.
22. Riggs BL, Khosla S, Melton LJ 3rd. Sex steroids
and the construction and conservation of the adult
skeleton. Endocr Rev. 2002; 23(3): 279-302.
23. Boroňová I, Bernasovská J, Mačeková S, Petrejčíková
E, Tomková Z, Kľoc J, et al. TNFRSF11B gene polymorphisms,
bone mineral density, and fractures in
Slovak postmenopausal women. J Appl Genet. 2015;
56(1): 57-63.
24. Gavali S, Gupta MK, Daswani B, Wani MR, Sirdeshmukh
R, Khatkhatay MI. LYN, a key mediator
in estrogen-dependent suppression of osteoclast differentiation,
survival, and function. Biochim Biophys
Acta Mol Basis Dis. 2019; 1865(3): 547-557.
25. Kim JH, Kim EY, Lee B, Min JH, Song DU, Lim JM,
et al. The effects of Lycii Radicis Cortex on RANKLinduced
osteoclast differentiation and activation in
RAW 264.7 cells. Int J Mol Med. 2016; 37(3): 649-
658.
26. Kim K, Lee SH, Kim JH, Choi Y, Kim N. NFATc1
induces osteoclast fusion via up-regulation of Atp6v0d2
and the dendritic cell-specific transmembrane
protein (DC-STAMP). Mol Endocrinol. 2008; 22(1):
176-185.
27. Zhao Q, Wang X, Liu Y, He A, Jia R. FATc1: Functions
in osteoclasts. Int J Biochem Cell Biol. 2010;
42(5): 576-579.
28. Winslow MM, Pan M, Starbuck M, Gallo EM, Deng
L, Karsenty G, et al. Calcineurin/NFAT signaling
in osteoblasts regulates bone mass. Dev Cell. 2006;
10(6): 771-782.
29. Xu J, Wu HF, Ang ESM, Yip K, Woloszyn M, Zheng
MH, et al. NF-kappaB modulators in osteolytic bone
diseases. Cytokine Growth Factor Rev. 2009; 20(1):
7-17.
|
|
|
|
 |
Number 27
VOL. 27 (2), 2024 |
Number 27
VOL. 27 (1), 2024 |
Number 26
Number 26 VOL. 26(2), 2023 All in one |
Number 26
VOL. 26(2), 2023 |
Number 26
VOL. 26, 2023 Supplement |
Number 26
VOL. 26(1), 2023 |
Number 25
VOL. 25(2), 2022 |
Number 25
VOL. 25 (1), 2022 |
Number 24
VOL. 24(2), 2021 |
Number 24
VOL. 24(1), 2021 |
Number 23
VOL. 23(2), 2020 |
Number 22
VOL. 22(2), 2019 |
Number 22
VOL. 22(1), 2019 |
Number 22
VOL. 22, 2019 Supplement |
Number 21
VOL. 21(2), 2018 |
Number 21
VOL. 21 (1), 2018 |
Number 21
VOL. 21, 2018 Supplement |
Number 20
VOL. 20 (2), 2017 |
Number 20
VOL. 20 (1), 2017 |
Number 19
VOL. 19 (2), 2016 |
Number 19
VOL. 19 (1), 2016 |
Number 18
VOL. 18 (2), 2015 |
Number 18
VOL. 18 (1), 2015 |
Number 17
VOL. 17 (2), 2014 |
Number 17
VOL. 17 (1), 2014 |
Number 16
VOL. 16 (2), 2013 |
Number 16
VOL. 16 (1), 2013 |
Number 15
VOL. 15 (2), 2012 |
Number 15
VOL. 15, 2012 Supplement |
Number 15
Vol. 15 (1), 2012 |
Number 14
14 - Vol. 14 (2), 2011 |
Number 14
The 9th Balkan Congress of Medical Genetics |
Number 14
14 - Vol. 14 (1), 2011 |
Number 13
Vol. 13 (2), 2010 |
Number 13
Vol.13 (1), 2010 |
Number 12
Vol.12 (2), 2009 |
Number 12
Vol.12 (1), 2009 |
Number 11
Vol.11 (2),2008 |
Number 11
Vol.11 (1),2008 |
Number 10
Vol.10 (2), 2007 |
Number 10
10 (1),2007 |
Number 9
1&2, 2006 |
Number 9
3&4, 2006 |
Number 8
1&2, 2005 |
Number 8
3&4, 2004 |
Number 7
1&2, 2004 |
Number 6
3&4, 2003 |
Number 6
1&2, 2003 |
Number 5
3&4, 2002 |
Number 5
1&2, 2002 |
Number 4
Vol.3 (4), 2000 |
Number 4
Vol.2 (4), 1999 |
Number 4
Vol.1 (4), 1998 |
Number 4
3&4, 2001 |
Number 4
1&2, 2001 |
Number 3
Vol.3 (3), 2000 |
Number 3
Vol.2 (3), 1999 |
Number 3
Vol.1 (3), 1998 |
Number 2
Vol.3(2), 2000 |
Number 2
Vol.1 (2), 1998 |
Number 2
Vol.2 (2), 1999 |
Number 1
Vol.3 (1), 2000 |
Number 1
Vol.2 (1), 1999 |
Number 1
Vol.1 (1), 1998 |
|
|
